Thrombosis Clinical Trials

A listing of Thrombosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arkansas

UPDATED

Little Rock Arkansas 72202-3591

A clinical research study of Apixaban for the treatment of Thromboembolism

UPDATED

Little Rock Arkansas 72202

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Thrombosis

California

UPDATED

La Jolla California 92093-0641

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

UPDATED

Los Angeles California 90095

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Oakland California 94609

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Thrombosis

Connecticut

UPDATED

Hartford Connecticut 06106

A clinical research study of Apixaban for the treatment of Thromboembolism

District of Columbia

UPDATED

Washington District of Columbia 20007

A clinical research study of Apixaban for the treatment of Thromboembolism

Florida

UPDATED

Tampa Florida 33606

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Georgia

UPDATED

Atlanta Georgia 30322

A clinical research study of Apixaban for the treatment of Thromboembolism

Illinois

UPDATED

Oak Lawn Illinois 60453-2699

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Indiana

UPDATED

Indianapolis Indiana 46202

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

UPDATED

Indianapolis Indiana 46260

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Thrombosis

Kentucky

UPDATED

Louisville Kentucky 40202

A clinical research study of Apixaban for the treatment of Thromboembolism

UPDATED

Louisville Kentucky 40202

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Massachusetts

UPDATED

Boston Massachusetts 02115

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

Michigan

UPDATED

Ann Arbor Michigan 48109-5247

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

UPDATED

Grand Rapids Michigan 49503

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Minnesota

UPDATED

Minneapolis Minnesota 55404

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Missouri

UPDATED

Kansas City Missouri 64108

A clinical research study of Apixaban for the treatment of Thromboembolism

UPDATED

St. Louis Missouri 63110

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

New York

UPDATED

Albany New York 12208

A clinical trial seeking patients for a research study for the treatment of Hemodialysis Access or Thrombosis

North Carolina

UPDATED

Charlotte North Carolina 28210

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Charlotte North Carolina 28203

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Thrombosis

UPDATED

Greenville North Carolina 27858

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Ohio

UPDATED

Cincinnati Ohio 45229

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

UPDATED

Columbus Ohio 43205-2696

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Thrombosis

UPDATED

Toledo Ohio 43606

A clinical research study of Apixaban for the treatment of Thromboembolism

Oklahoma

UPDATED

Oklahoma City Oklahoma 73104

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19104

A clinical research study of Apixaban for the treatment of Thromboembolism

UPDATED

Philadelphia Pennsylvania 19104

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

South Carolina

UPDATED

Charleston South Carolina 29425

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

Tennessee

UPDATED

Memphis Tennessee 38105

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Memphis Tennessee 38105

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Texas

UPDATED

Houston Texas 77030-2399

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

Utah

UPDATED

Salt Lake City Utah 84113

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

Wisconsin

UPDATED

Milwaukee Wisconsin 53226

A clinical research study of Apixaban for the treatment of Thromboembolism

UPDATED

Milwaukee Wisconsin 53226-4874

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Australia

UPDATED

Parkville Victoria 3052

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

Austria

UPDATED

Vienna 1090

A clinical research study of Apixaban, Vitamin K Antagonist (VKA) and Low Molecular Weight Heparin (LMWH) for the treatment of Thrombosis

Belgium

UPDATED

Leuven 3000

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Thrombosis

UPDATED

Many Locations

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY 59-7939) for the treatment of Venous Thrombosis and Pulmonary Embolism

Brazil

UPDATED

Passo Fundo Rio Grande do Sul 99010-080

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Pôrto Alegre Rio Grande do Sul 90620-001

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Sao Paulo 01227-200

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Votuporanga Sao Paulo 15500-003

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

Canada

UPDATED

Edmonton Alberta T6G 2B7

A clinical research study of Edoxaban and Standard of Care for the treatment of Venous Thromboembolism (VTE), Pulmonary Embolism or Deep Vein Thrombosis (DVT)

UPDATED

Edmonton Alberta T6G 2B7

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Thrombosis

UPDATED

Hamilton Ontario L8S 4K1

A clinical research study of Apixaban for the treatment of Thromboembolism